Archive: 08/17/2012

Study reveals new molecular target for melanoma treatment

A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to play essential role in melanoma that has not been ...

Aug 17, 2012
popularity 5 / 5 (1) | comments 0 | with audio podcast

Good transplant outcomes in hypertrophic cardiomyopathy

(HealthDay) -- Post-heart transplant survival does not differ significantly between patients with hypertrophic cardiomyopathy (HC) and those with other types of heart disease, according to a study published in the Aug. 15 ...

Aug 17, 2012
popularity not rated yet | comments 0

Considerable variation in outcomes for cleft lip/Palate

(HealthDay) -- There is considerable variation in the neuropsychological, behavioral, and academic outcomes of individuals with cleft lip and palate, as the outcomes are affected by developmental level, sex, ...

Aug 17, 2012
popularity not rated yet | comments 0 | with audio podcast